Zobrazeno 1 - 10
of 47
pro vyhledávání: '"11"'
Autor:
Mario Anders, Jessica Becker, Christian Gerges, Claudia Fuchs, Tania Noder, Jakob R. Izbicki, Hauke Lang, Marino Venerito, Claire Palles, Susanne Moebus, Julia Schröder, Heide Loehlein Fier, Christian Ell, Lothar Veits, René Thieme, Janusz Jankowski, Nicole Kreuser, Yusef Moulla, Arne Dietrich, Dietmar Lorenz, Thomas Rösch, Puya Gharahkhani, Yogesh K. Vashist, Ines Gockel, Anne C. Böhmer, Thomas Schmidt, Horst Neuhaus, Brigitte Schumacher, Markus M. Nöthen, Michael Knapp, Michael Vieth, Rupert Mayershofer, Andrea May, Johannes Schumacher, Orestis Lyros, Josef Weismüller, Katja Ott, Julian Hecker, Thomas L. Vaughan, Ian Tomlinson, Timo Hess, David C. Whiteman, Rebecca C. Fitzgerald, Aaron P. Thrift, Arnulf H. Hölscher
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention, 29, 427-433
Cancer Epidemiology, Biomarkers & Prevention, 29, 2, pp. 427-433
Cancer Epidemiology, Biomarkers & Prevention, 29, 2, pp. 427-433
Background: Obesity is a major risk factor for esophageal adenocarcinoma (EA) and its precursor Barrett's esophagus (BE). Research suggests that individuals with high genetic risk to obesity have a higher BE/EA risk. To facilitate understanding of bi
Autor:
Suzanne Miyamoto, David R. Gandara, Kyoungmi Kim, Karen Kelly, Brian C. DeFelice, Ken Y. Yoneda, Sandra L. Taylor, David T. Cooke, Oliver Fiehn, Johannes F. Fahrmann
Publikováno v:
Fahrmann, JF; Kim, K; DeFelice, BC; Taylor, SL; Gandara, DR; Yoneda, KY; et al.(2015). Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer. Cancer Epidemiology Biomarkers and Prevention, 24(11), 1716-1723. doi: 10.1158/1055-9965.EPI-15-0427. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/1dj8m7wn
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 24, iss 11
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 24, iss 11
Background: Untargeted metabolomics was used in case–control studies of adenocarcinoma (ADC) lung cancer to develop and test metabolite classifiers in serum and plasma as potential biomarkers for diagnosing lung cancer. Methods: Serum and plasma we
Autor:
Ladan Zolfghari, Shelley Niwa, Carmela Veneroso, Barlow Lynch, Paul H. Levine, Ann W. Hsing, Michael J. Manyak, Peter R. Carroll, Isabell A. Sesterhann, George P. Hemstreet, Ruth M. Pfeiffer, Cindy Ke Zhou, Michael B. Cook, Muhannad Hafi, Yu-Tang Gao, Roni T. Falk, Shannon N. Wood, Eric Emanuel, Frank Z. Stanczyk
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 26, iss 11
Background: Sex hormones have been implicated in prostate carcinogenesis, yet epidemiologic studies have not provided substantiating evidence. We tested the hypothesis that circulating concentrations of sex steroid hormones reflect intraprostatic con
Autor:
W. Torre, Gorka Bastarrika, Maria J. Pajares, Javier J. Zulueta, Luis M. Montuenga, Ana Remirez, Ruben Pio, Jackeline Agorreta, Isabel Zudaire, Maria D. Lozano
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 15:373-380
Rationale and Purpose: Low-dose spiral computerized axial tomography (spiral CT) is effective for the detection of small early lung cancers. Although published data seem promising, there has been a significant degree of discussion concerning the pote
Autor:
Shaniece Theodore, Melissa Davis, Jhong Rhim, Timothy Turner, Honghe Wang, Clayton Yates, William E. Grizzle
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 23:PL01-02
Prostate cancer is the most commonly diagnosed malignancy in men, with African American men experiencing a rate 60% higher than white patients. At the time of diagnosis, approximately 50% of men have clinically advanced disease. African American men
Autor:
Li Tang, Yue Wu, James L. Mohler, Zinian Wang, Gary J. Smith, Clayton M. Shanahan, Gissou Azabdaftari, Elizabeth T. H. Fontham, Qianqian Zhu, Elena Pop, Jeannette T. Bensen
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: Androgen receptor signaling is crucial to prostate cancer aggressiveness. Members of the solute carrier family of the organic anion transporting peptides (SLCO) are potential regulators of androgen availability in prostate tissue. It rema
Autor:
David C. Christiani, Sanjay Shete, Paul Brennan, Ping Yang, Yonathan Brhane, Keitaro Matsuo, Christopher I. Amos, Rayjean J. Hung, Yohan Bossé, John K. Field, John R. McLaughlin, Geoffrey Liu, Takashi Kohno, Adonina Tardón, Kouya Shiraishi
Publikováno v:
Cancer Epidemiol Biomarkers Prev
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Background: Lung cancer remains the leading cause of cancer death worldwide, with 15% to 20% occurring in never smokers. To assess genetic determinants for prognosis among never smokers, we conducted a genome-wide investigation in the International L
Autor:
Jarmo Virtamo, Lee E. Moore, Ruth M. Pfeiffer, Nathaniel Rothman, Debra T. Silverman, Demetrius Albanes, Linda M. Liao, Sara Karami, Stephanie J. Weinstein, Gabriella Andreotti, Lauren M. Hurwitz
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 21:PR1-PR1
Background: Low global methylation levels measured in post-diagnostic case compared to healthy control blood DNA have been associated with elevated bladder cancer risk. Objective: To examine this association using blood DNA collected prior to bladder
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 27:1358-1363
Background: Borderline ovarian tumors (BOTs) are a subgroup of ovarian malignancies with low malignant potential. Very limited earlier data are available on familial clustering of BOTs with other cancers. We aim to explore histology-specific familial
Autor:
Jim C. Hu, Padraic O'Malley, Brian H. Eisner, Daniel Shoag, Sameer Mittal, Peter N. Schlegel, Oleksander Savenkov, Christopher E. Barbieri, Daniel J. Lee, Ron Golan, Douglas S. Scherr, Jonathan Shoag, Bobby B. Najari, Gulce Askin, Joshua A. Halpern, Paul J. Christos
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 26:1653-1659
Background: Vasectomy has been implicated as a risk factor for prostate cancer in multiple epidemiologic studies over the past 25 years. Whether this relationship is causal remains unclear. This study examines the association between vasectomy and pr